Clinical trial
Topical Insulin Drops for the Treatment of Neurotrophic Keratopathy.
NCT05321251 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Topical Insulin Drops for the Treatment of Neurotrophic Keratopathy.
- Lead sponsor
- University of Alberta
- Phase
- Phase 2/3
- Overall status
- Withdrawn
- Start date
- June 1, 2022
- Completion date
- October 18, 2023
- Enrollment
- 0 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
neurotrophic keratitis